276 research outputs found
Travel diaries as a source for creative constructions of thepast and the present: The Edward Bliss EmersonCaribbean diary (1831-1832)
The panelists will describe their particular encounters with Edward B. Emerson‟s travel diary, emphasizing their approaches to analyzing its content. They will describe the resources and techniques they employed to expand and contextualize Edward‟s account. They will offer the audience a truly interdisciplinary and creative interpretation of Edward‟s diary that could serve as an example of how to approach other travel diaries. Its diversity of subject and tone will be addressed by a group of scholars from different backgrounds. Collectively, the panelists represent 15 disciplines that provide different viewpoints in the analysis
Dengue fever in pregnancy: a case report
<p>Abstract</p> <p>Background</p> <p>Dengue, a mosquito-borne flavivirus infection, is endemic in Southeast Asia. Currently, the incidence has been increasing among adults.</p> <p>Case presentation</p> <p>A 26-year-old Thai woman, G<sub>1</sub>P<sub>0</sub> 31 weeks pregnancy, presented with epigastric pain for 1 day. She also had a high-grade fever for 4 days. The physical examination, complete blood counts as well as serology confirmed dengue fever. The patient was under conservative treatment despite severe thrombocytopenia. She was well at the 3<sup>rd</sup> day of discharge and 1-week follow-up. The pregnancy continued until term without any complication and she delivered vaginally a healthy female baby.</p> <p>Conclusions</p> <p>More cases of dengue infection in pregnancy can be found due to the increasing incidence during adulthood. It should be suspected when a pregnant woman presents with symptoms and signs like in a non-pregnant. Conservative treatment should be conducted unless there are any complications.</p
Endurance, Refuge, and Reemergence of Dengue Virus Type 2, Puerto Rico, 1986–2007
To study the evolution of dengue virus (DENV) serotype 2 in Puerto Rico, we examined the genetic composition and diversity of 160 DENV-2 genomes obtained through 22 consecutive years of sampling. A clade replacement took place in 1994–1997 during a period of high incidence of autochthonous DENV-2 and frequent, short-lived reintroductions of foreign DENV-2. This unique clade replacement was complete just before DENV-3 emerged. By temporally and geographically defining DENV-2 lineages, we describe a refuge of this virus through 4 years of low genome diversity. Our analyses may explain the long-term endurance of DENV-2 despite great epidemiologic changes in disease incidence and serotype distribution
Dengue Deaths in Puerto Rico: Lessons Learned from the 2007 Epidemic
Dengue is a major public health problem in the tropics and subtropics; an estimated 50 million cases occur annually and 40 percent of the world's population lives in areas with dengue virus (DENV) transmission. Dengue has a wide range of clinical presentations from an undifferentiated acute febrile illness, classic dengue fever, to severe dengue (i.e., dengue hemorrhagic fever or dengue shock syndrome). About 5% of patients develop severe dengue, which is more common with second or subsequent infections. No vaccines are available to prevent dengue, and there are no specific antiviral treatments for patients with dengue. However, early recognition of shock and intensive supportive therapy can reduce risk of death from ∼10% to less than 1% among severe dengue cases. Reviewing dengue deaths is one means to identify issues in clinical management. These findings can be used to develop healthcare provider education to minimize dengue morbidity and mortality
HiTZ@Antidote: Argumentation-driven Explainable Artificial Intelligence for Digital Medicine
Providing high quality explanations for AI predictions based on machine
learning is a challenging and complex task. To work well it requires, among
other factors: selecting a proper level of generality/specificity of the
explanation; considering assumptions about the familiarity of the explanation
beneficiary with the AI task under consideration; referring to specific
elements that have contributed to the decision; making use of additional
knowledge (e.g. expert evidence) which might not be part of the prediction
process; and providing evidence supporting negative hypothesis. Finally, the
system needs to formulate the explanation in a clearly interpretable, and
possibly convincing, way. Given these considerations, ANTIDOTE fosters an
integrated vision of explainable AI, where low-level characteristics of the
deep learning process are combined with higher level schemes proper of the
human argumentation capacity. ANTIDOTE will exploit cross-disciplinary
competences in deep learning and argumentation to support a broader and
innovative view of explainable AI, where the need for high-quality explanations
for clinical cases deliberation is critical. As a first result of the project,
we publish the Antidote CasiMedicos dataset to facilitate research on
explainable AI in general, and argumentation in the medical domain in
particular.Comment: To appear: In SEPLN 2023: 39th International Conference of the
Spanish Society for Natural Language Processin
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever
A prospective cohort study was performed in 50 patients with dengue haemorrhagic fever (DHF) to determine the potential role of the contact activation system and factor XI activation (intrinsic pathway) in the coagulation disorders in DHF. To establish whether TAFI (thrombin-activatable fibrinolysis inhibitor) was involved in the severity of the coagulation disorders, the TAFI antigen and activity levels were also determined. Markers of contact activation (kallikrein--C1-inhibitor complexes), the intrinsic pathway of coagulation (factor XIa--C1-inhibitor complexes) and TAFI were measured and correlated to thrombin generation markers (thrombin--anti-thrombin complexes (TAT), prothrombin fragment 1+2 (F1+2)) and a marker for fibrinolysis [plasmin--alpha 2--anti-plasmin complexes (PAP)]. Activation of the intrinsic pathway of coagulation was clearly demonstrated by elevated levels of factor XIa--C1-inhibitor complexes, without evidence of contact activation, reflected by undetectable kallikrein--C1-inhibitor complexes. Both TAFI antigen and activity levels were decreased in all patients, which may contribute to the severity of bleeding complications in DHF because of the impaired capacity of the coagulation system to protect the fibrin clot from fibrinolysis. These findings in a human viral infection model are in accordance with earlier findings in bacterial sepsi
- …